// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
In conversations about the role of quality standards in public health, you might come across the
The opioid crisis in the U.S.
The Root Causes of Substandard Medicines in Lower and Middle Income Countries (LMICs)